3
Participants
Start Date
October 31, 2008
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
rhIGF (Increlex)
rhIGF will be administered as a subcutaneous injection per the following schema: First 2 weeks: 40 mcg/kg BID; Weeks 3 and 4: 80 mcg/kg BID; Subsequent weeks: 120 mcg/kg BID.
Nationwide Children's Hospital, Columbus
Collaborators (1)
Tercica
INDUSTRY
Nationwide Children's Hospital
OTHER